VIVAT NV receives EUR 1.35 billion capital injection from Anbang Insurance Group
23 October 2015
VIVAT NV (VIVAT) announces that it has received a capital injection of EUR 1.35 billion from Anbang Insurance Group Co., Ltd. (Anbang Insurance Group).
As a result of the capital injection, the Solvency I ratio of VIVAT will increase to 233% (based on pro forma 30 June 2015 figures) and the Solvency II ratio to above 150% (based on standard model pro forma 30 June 2015 figures).
VIVAT is a leading insurance and asset management company in the Netherlands with a history of more than 100 years. It enjoys a strong client base and solid reputation. The capital injection from Anbang Insurance Group will further consolidate its position as a strong, stable financial institution, offering its customers and employees greater stability and continuity.